International project develops heart device suited to Japanese market:
This article was originally published in Clinica
Each year, 2,000-3,000 Japanese patients require artificial hearts, but are unable to acquire one due to the high cost and large size of conventional pumps, which are unsuitable for many Japanese people. Recently, the Tokyo Women's Medical University (in liaison with researchers from Waseda University, Sun Medical Technology Research and the US University of Pittsburgh) successfully implanted a small-sized blood pump, reports Asahi Shimbun. The Evaheart is 420 grams, which means it can be used in smaller women and children. The device costs around Y5m ($46,000), which is less than half the price of foreign pumps. It is hoped that the new pump will encourage more manufacturing of implant devices in Japan.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.